BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27214807)

  • 1. Clinical outcome of HIV-infected haemophiliac patients in Hong Kong.
    Lee CK; Hui CH; Lie AK; Liang R; Chan TK
    Haemophilia; 1997 Jul; 3(3):205-8. PubMed ID: 27214807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years of clinical human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in Hong Kong.
    Wong KH; Lee SS; Chan KC
    Hong Kong Med J; 2006 Apr; 12(2):133-40. PubMed ID: 16603781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy.
    Chitra P; Bakthavatsalam B; Palvannan T
    Clin Chim Acta; 2011 May; 412(11-12):1151-4. PubMed ID: 21300045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
    Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
    Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CD4 count or CD4/CD8 ratio as a useful indicator for postoperative sepsis in HIV-infected patients undergoing abdominal operations.
    Xia XJ; Liu BC; Su JS; Pei H; Chen H; Li L; Liu YF
    J Surg Res; 2012 May; 174(1):e25-30. PubMed ID: 22225978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intermediate- and high-purity factor VIII concentrates on immune function in HIV-seropositive haemophiliacs as assessed by quantitative CD 4 counts.
    Deitcher SR; Tuller J; Dugdale M
    Haemophilia; 1997 Oct; 3(4):265-9. PubMed ID: 27214862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first one hundred AIDS cases in Hong Kong.
    Lee SS; Lo YC; Wong KH
    Chin Med J (Engl); 1996 Jan; 109(1):70-6. PubMed ID: 8758375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.
    Ashton LJ; Carr A; Cunningham PH; Roggensack M; McLean K; Law M; Robertson M; Cooper DA; Kaldor JM
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):117-21. PubMed ID: 9462921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
    Lorenzo JI; Molina R; Aznar JA
    Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of a very high-purity factor VIII concentrate on the immune system of HIV-infected haemophiliacs: a randomized, two-year comparison with a high-purity concentrate.
    de Biasi R; Rocino A; Quirino AA; Miraglia E; Ziello L
    Haemophilia; 1996 Apr; 2(2):82-7. PubMed ID: 27214013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.